{
    "nct_id": "NCT03758404",
    "official_title": "An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2/8-hG1.7p.coCNGA3) for Gene Therapy of Children and Adults With Achromatopsia Owing to Defects in CNGA3",
    "inclusion_criteria": "* Are aged years or over\n* Have achromatopsia confirmed by a retinal specialist investigator\nHealthy volunteers allowed\nMust have minimum age of 3 Years",
    "exclusion_criteria": "* Are females who are pregnant or breastfeeding\n* Have participated in another research study involving an investigational medicinal therapy for ocular disease within the last 6 months\n* Have any other condition that the investigator considers makes them inappropriate for entry into the trial",
    "miscellaneous_criteria": ""
}